Actively Recruiting

Age: 18Years +
All Genders
NCT05965024

Exploration on the Value of MRD Based on ctDNA Detection in Predicting Recurrence of Resected Non-small Cell Lung Cancer

Led by Shanghai Pulmonary Hospital, Shanghai, China · Updated on 2024-02-21

377

Participants Needed

1

Research Sites

248 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Based on the unique patented MONOD and Methyl Titan methylation sequencing technology on lung cancer tissue and blood samples, a lung cancer MRD monitoring panel is designed. The panel is used to detect molecular residual disease of stage IB-IIIB non-small cell lung cancer patients underwent radical surgery, explore personalized analysis models, and conduct research on recurrence monitoring for non-small cell lung cancer patients.

CONDITIONS

Official Title

Exploration on the Value of MRD Based on ctDNA Detection in Predicting Recurrence of Resected Non-small Cell Lung Cancer

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Age 18 years or older
  • Diagnosed with non-small cell lung cancer at clinical stage IB to IIIB
  • Able to undergo radical surgical treatment
  • Physical condition score (ECOG) of 1 or less
  • Expected survival time longer than 24 months
  • Willing to participate and sign informed consent
Not Eligible

You will not qualify if you...

  • History of other malignant tumors within the last 5 years
  • Received neoadjuvant therapy before surgery
  • Postoperative incision margin classified as R1 or R2
  • Blood transfusion within 2 weeks before surgery
  • Having systemic inflammatory response syndrome
  • Serious diseases affecting heart, lungs, kidneys, or brain
  • Participated in other clinical trials and taken experimental drugs within 30 days
  • Incomplete or unsuitable sample collection
  • Considered unsuitable for participation by researchers

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Shanghai Pulmonary Hospital

Shanghai, Shanghai Municipality, China, 200433

Actively Recruiting

Loading map...

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

0

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here